Literature DB >> 22990986

Wearable and implantable pancreas substitutes.

Leonardo Ricotti1, Tareq Assaf, Paolo Dario, Arianna Menciassi.   

Abstract

A lifelong-implanted and completely automated artificial or bioartificial pancreas (BAP) is the holy grail for type 1 diabetes treatment, and could be a definitive solution even for other severe pathologies, such as pancreatitis and pancreas cancer. Technology has made several important steps forward in the last years, providing new hope for the realization of such devices, whose feasibility is strictly connected to advances in glucose sensor technology, subcutaneous and intraperitoneal insulin pump development, the design of closed-loop control algorithms for mechatronic pancreases, as well as cell and tissue engineering and cell encapsulation for biohybrid pancreases. Furthermore, smart integration of the mentioned components and biocompatibility issues must be addressed, bearing in mind that, for mechatronic pancreases, it is most important to consider how to recharge implanted batteries and refill implanted insulin reservoirs without requiring periodic surgical interventions. This review describes recent advancements in technologies and concepts related to artificial and bioartificial pancreases, and assesses how far we are from a lifelong-implanted and self-working pancreas substitute that can fully restore the quality of life of a diabetic (or other type of) patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990986     DOI: 10.1007/s10047-012-0660-6

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  97 in total

Review 1.  Small-scale systems for in vivo drug delivery.

Authors:  David A LaVan; Terry McGuire; Robert Langer
Journal:  Nat Biotechnol       Date:  2003-10       Impact factor: 54.908

2.  The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas).

Authors:  A M Sun; W Parisius; G M Healy; I Vacek; H G Macmorine
Journal:  Diabetes       Date:  1977-12       Impact factor: 9.461

3.  Evaluation of the antimicrobial activity of lysostaphin-coated hernia repair meshes.

Authors:  Rohan Satishkumar; Sriram Sankar; Yuliya Yurko; Amy Lincourt; John Shipp; B Todd Heniford; Alexey Vertegel
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 4.  A new approach to diabetic control: fuzzy logic and insulin pump technology.

Authors:  Paul Grant
Journal:  Med Eng Phys       Date:  2006-10-18       Impact factor: 2.242

5.  Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation.

Authors:  Robert B Elliott; Livia Escobar; Paul L J Tan; Maria Muzina; Sahar Zwain; Christina Buchanan
Journal:  Xenotransplantation       Date:  2007-03       Impact factor: 3.907

Review 6.  Closing the loop.

Authors:  E Dassau; E Atlas; M Phillip
Journal:  Int J Clin Pract Suppl       Date:  2011-02

7.  Insulin delivery route for the artificial pancreas: subcutaneous, intraperitoneal, or intravenous? Pros and cons.

Authors:  Eric Renard
Journal:  J Diabetes Sci Technol       Date:  2008-07

Review 8.  Perspectives in diabetes. Islet transplantation with immunoisolation.

Authors:  R P Lanza; S J Sullivan; W L Chick
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

9.  Development of the Biostator Glucose clamping algorithm.

Authors:  A H Clemens; D L Hough; P A D'Orazio
Journal:  Clin Chem       Date:  1982-09       Impact factor: 8.327

10.  Development of an enzyme-free glucose sensor using the gate effect of a molecularly imprinted polymer.

Authors:  Yasuo Yoshimi; Akisato Narimatsu; Keisuke Nakayama; Shinichi Sekine; Koji Hattori; Kiyotaka Sakai
Journal:  J Artif Organs       Date:  2009-12-25       Impact factor: 1.731

View more
  8 in total

1.  Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Authors:  Howard Zisser; Eyal Dassau; Justin J Lee; Rebecca A Harvey; Wendy Bevier; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

Review 2.  Islet cell xenotransplantation: a serious look toward the clinic.

Authors:  Kannan P Samy; Benjamin M Martin; Nicole A Turgeon; Allan D Kirk
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

Review 3.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

4.  Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.

Authors:  Beata Chertok; Matthew J Webber; Marc D Succi; Robert Langer
Journal:  Mol Pharm       Date:  2013-08-26       Impact factor: 4.939

5.  Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.

Authors:  Marc Folcher; Sabine Oesterle; Katharina Zwicky; Thushara Thekkottil; Julie Heymoz; Muriel Hohmann; Matthias Christen; Marie Daoud El-Baba; Peter Buchmann; Martin Fussenegger
Journal:  Nat Commun       Date:  2014-11-11       Impact factor: 14.919

6.  Autonomous device for application in late-phase hemorrhagic shock prevention.

Authors:  Vlad Oncescu; Seoho Lee; Abdurrahman Gumus; Kolbeinn Karlsson; David Erickson
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

7.  Effect of sensor location on continuous intraperitoneal glucose sensing in an animal model.

Authors:  Marte Kierulf Åm; Konstanze Kölle; Anders Lyngvi Fougner; Ilze Dirnena-Fusini; Patrick Christian Bösch; Reinold Ellingsen; Dag Roar Hjelme; Øyvind Stavdahl; Sven Magnus Carlsen; Sverre Christian Christiansen
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

8.  Investigation of drug release modulation from poly(2-oxazoline) micelles through ultrasound.

Authors:  Alice Rita Salgarella; Anna Zahoranová; Petra Šrámková; Monika Majerčíková; Ewa Pavlova; Robert Luxenhofer; Juraj Kronek; Igor Lacík; Leonardo Ricotti
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.